Johnson & Johnson Looks To Sell Diagnostics UnitVW Staff
Johnson & Johnson (NYSE:JNJ) is readying financial information and legal forms in order to sell one of its diagnostics businesses. Dow Jones reported that the diversified healthcare company has JPMorgan Chase & Co (NYSE:JPM) advising it on the sale, and the business could fetch as much as $5 billion.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.